As multidrug resistance (MDR) of anticancer drug like taxanes and vinca alkaloids has become a serious problem in cancer chemotherapy [10,11], the Eg5 inhibitors have been tested for their susceptibility to the PgP efflux pump and some of them have been validated for greater potential to overcome MDR [12]. The gene discussed is KIF11; the disease is cancer.